Towards building truly global professional associations: the role of international congresses  by Brewer, Timothy R. & Butzler, Jean-Paul
Editorial 
Towards building truly global professional associations: the 
role of international congresses 
Timothy E Brewer and Jean-Paul Butzler 
In March of 2002, the International Society for Infec- 
tious Diseases will sponsor the 10th International 
Congress on Infectious Diseases (ICID). Anniversaries 
are a natural time to reflect, and it is worthwhile to 
reconsider the role of international meetings in today’s 
world. Much has changed since the first ICID almost 20 
years ago. The Internet now provides rapid access to 
information almost anywhere in the world, and com- 
munications technologies enable individuals to view 
presentations in different countries without having to 
travel. Regional meetings in medical subspecialties such 
as infectious diseases seem to have increased in number 
and quality, lessening the need to go to an international 
meeting to learn the latest advances in research and 
clinical care. Yet as access to knowledge has spread 
around the globe, so too has the realization of the need 
for international solutions to control infectious diseases. 
A scant 40 years ago, Nobel Laureate Frank Burnet 
wrote that infectious diseases had been eliminated as an 
important cause of morbidity and mortality;l today 
infectious diseases are on the forefront of human con- 
cern. In sub-Saharan Africa, an entire region is facing 
social and economic collapse from the human immuno- 
deficiency virus (HIV) pandemic2 Antibiotic resistance, 
the emergence of new pathogens, and the spread of 
existing infectious agents to new environments all 
threaten our ability to control infectious diseases. What 
role do international meetings such as the ICID have in 
overcoming these challenges? 
In contrast to regional or national meetings, inter- 
national meetings provide a occasion to bring together 
individuals from both developed and developing 
countries; the congress is an opportunity to exchange 
ideas, establish collaborations and develop international 
training and research programs.3 This exchange is an 
essential component of an international meeting, and is 
one rationale for continuing with international meetings 
This work was supported by the U.S. Centers for Disease Control and 
Prevention, Atlanta, GA through a collaborative agreement with the 
Association of Schools of Public Health and a Clinical Investigator 
Award #lKOS AI01444-OlAl from the National Institute of Allergy 
and Infectious Diseases. 
Please address correspondence and reprints requests to: Dr. Timothy 
Brewer, Channing Laboratory, 181 Longwood Ave, Boston, MA 02115, 
telephone: (617) 5250846, fax: (617) 525-0958, e-mail: timothy.brewer 
@channing.harvard.edu 
despite the availability of high-quality regional and 
national ones. Though in theory the integration of 
developed and developing country colleagues is a 
valuable reason for an international meeting, in practice 
this integration has been problematic. Even when their 
countries bare the brunt of a disease such as acquired 
immunodeficiency syndrome (AIDS), researchers from 
developing countries have been underrepresented in the 
scientific programs and audiences of international meet- 
ings.4 When developing country scientists do participate, 
delegates may be less interested in their presentations 
than those by potentially more prominent developed 
country scientists.5 
International meetings pose other unique problems. 
There may be security concerns for international 
travelers, and meetings may be affected by political 
events both in and out of the host country.(j The high cost 
of travel is a real barrier, both for organizers and for 
potential attendees. Because of these costs, organizers 
are faced with trying to obtain sufficient financial support 
and attendance to sustain the meeting.7 Delegates may 
be dependent on pharmaceutical companies to attend 
international meetings. Sixty-seven percent of physicians 
responding to an anonymous survey had received 
industry support to attend a recent World Congress of 
Gastroenterology. A majority of the respondents said 
that they would not have attended the meeting in the 
absence of industry sponsorship.8 International meet- 
ings are dependent on industry support to survive, and 
this dependence raises important ethical issues. For 
example, though access to antiretroviral treatments in 
low resource countries in Southern Africa was recog- 
nized as a major dilemma facing the care of persons with 
AIDS, there was no discussion of industry’s role in 
addressing this global health inequity at a major inter- 
national AIDS meeting where all the main companies 
were present.5 
Now more than ever, we will need global profes- 
sional partnerships to find solutions to today’s public 
health problems. The need for global partnerships is 
particularly true in infectious disease control. Rapid 
travel, the globalization of the world’s food supply, and 
population movements from immigration can and do 
disseminate infectious agents around the world. Control 
of infectious diseases in one country is increasingly 
dependent on control in all countries. Infectious disease 
research (especially clinical trials) also relies more and 
more on international collaborations. These collabor- 
ations raise equity, cultural and ethical issues in addition 
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to the standard scientific ones.9 Global partnerships 
can provide the links between public health officials, 
scientists, and clinicians in different regions of the world. 
To the extent that improving exchanges among scientists, 
public health officials and health care workers leads to 
increased understanding in political and other spheres, 
these links also may contribute to the broader goal of 
finding peaceful solutions to problems between countries 
and regions. 
To foster global partnerships, international meet- 
ings must be collaborative. Both the program and the 
audience should reflect the broader scientific and medical 
community. Besides including researchers from develop- 
ing countries and developed countries, groups such as 
public health officials, non-physician health care workers, 
social scientists and community groups involved in 
infectious diseases issues should participate. Meetings 
should address local and regional as well as inter- 
national issues, and should be used as an opportunity 
to support and build regional and local professional 
organizations and individuals. Addressing regionally 
specific topics, highlighting local as well as international 
researchers, and supporting local scientists and physicians 
to attend international meetings are examples of ways to 
enhance partnerships. 
The ICID can and should serve as a model of using 
a congress to create partnerships. By moving the 
Congress to different regions of the world, having local 
and regional scientific advisory boards to provide 
program input, and devoting approximately 20% of the 
scientific sessions to regional issues, the ICID seeks to 
attract a strong local as well as international partici- 
pation. After all, the first steps in building partnerships 
are bringing possible partners together and recognizing 
the challenges they have in common. Though the diffi- 
culties in developing truly collaborative and effective 
international scientific meetings are many, the potential 
reward in fostering global partnerships is worth the 
time, effort and risk. 
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